FDA Approves Human Genome (HGSI), Glaxo Drug Benlysta
March 10, 2011 at 01:54 AM EST
The first new drug to treat lupus in over 50 years won U.S. approval on Wednesday. Human Genome Sciences, Inc. (HGSI) and GlaxoSmithKline PLC (GSK) said that the U.S. Food and Drug Administration [FDA] has approved ‘Benlysta’, an injectable drug designed to relieve flare-ups and pain caused by the disabling disease. Benlysta was discovered by [...]